ASAH2
Basic information
Region (hg38): 10:50182778-50279720
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASAH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 0 |
Variants in ASAH2
This is a list of pathogenic ClinVar variants found in the ASAH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-50214744-C-G | not specified | Uncertain significance (Dec 14, 2021) | ||
10-50214780-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
10-50218534-C-A | not specified | Uncertain significance (Jul 11, 2023) | ||
10-50234545-T-G | not specified | Uncertain significance (Oct 05, 2021) | ||
10-50243242-C-T | not specified | Uncertain significance (Feb 01, 2023) | ||
10-50243257-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
10-50243351-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
10-50245244-C-A | not specified | Uncertain significance (Nov 07, 2023) | ||
10-50245346-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
10-50245361-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
10-50245386-G-A | not specified | Uncertain significance (Jul 27, 2022) | ||
10-50248499-T-C | not specified | Uncertain significance (Jun 03, 2022) | ||
10-50248512-G-C | not specified | Uncertain significance (Dec 15, 2022) | ||
10-50248514-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
10-50248547-C-T | not specified | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASAH2 | protein_coding | protein_coding | ENST00000395526 | 20 | 65833 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00427 | 0.877 | 124583 | 9 | 1156 | 125748 | 0.00464 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.346 | 123 | 134 | 0.916 | 0.00000686 | 5076 |
Missense in Polyphen | 38 | 39.644 | 0.95852 | 1949 | ||
Synonymous | -1.46 | 62 | 49.0 | 1.27 | 0.00000246 | 1516 |
Loss of Function | 1.32 | 5 | 9.36 | 0.534 | 5.62e-7 | 480 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0131 | 0.0130 |
Ashkenazi Jewish | 0.00397 | 0.00398 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00864 | 0.00863 |
European (Non-Finnish) | 0.00581 | 0.00578 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000849 | 0.000850 |
Other | 0.00391 | 0.00375 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 6.5-8.5 (PubMed:10781606, PubMed:26190575). Acts as a key regulator of sphingolipid signaling metabolites by generating sphingosine at the cell surface. Acts as a repressor of apoptosis both by reducing C16- ceramide, thereby preventing ceramide-induced apoptosis, and generating sphingosine, a precursor of the antiapoptotic factor sphingosine 1-phosphate. Probably involved in the digestion of dietary sphingolipids in intestine by acting as a key enzyme for the catabolism of dietary sphingolipids and regulating the levels of bioactive sphingolipid metabolites in the intestinal tract. {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:15946935, ECO:0000269|PubMed:16061940, ECO:0000269|PubMed:26190575}.;
- Pathway
- Sphingolipid signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;sphingosine and sphingosine-1-phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.129
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.168
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asah2
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- sphingosine metabolic process;ceramide metabolic process;apoptotic process;response to organic substance;long-chain fatty acid biosynthetic process;sphingosine biosynthetic process;ceramide catabolic process
- Cellular component
- extracellular region;mitochondrion;plasma membrane;integral component of membrane
- Molecular function
- calcium ion binding;zinc ion binding;N-acylsphingosine amidohydrolase activity;ceramidase activity